Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study - Scorecard - MDSpire

Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

  • By

  • Yang-Wei Cai

  • Jing-Wei Gao

  • Mao-Xiong Wu

  • Ze-Gui Huang

  • Guang-Hong Liao

  • Chuan-Rui Zeng

  • Pin-Ming Liu

  • Yang-Xin Chen

  • Jing-Feng Wang

  • Hai-Feng Zhang

  • November 13, 2025

  • 0 min

Share

Clinical Scorecard: Holistic Management of Multiple Risk Factors in Cancer Survivors to Reduce Heart Failure Incidence: Findings from a Prospective Cohort Analysis

At a Glance

CategoryDetail
ConditionHeart failure risk in cancer survivors
Key MechanismsCancer treatment cardiotoxicity (chemotherapy, radiotherapy), shared risk factors (hypertension, diabetes, obesity, smoking), lifestyle factors
Target PopulationCancer survivors aged 37-73 years
Care SettingCardio-oncology outpatient and primary care settings

Key Highlights

  • Cancer survivors have a higher incidence of heart failure compared to non-cancer individuals.
  • Joint control of multiple modifiable risk factors is associated with a graded reduction in heart failure risk.
  • Controlling at least five risk factors reduces heart failure risk in cancer survivors to levels comparable with matched non-cancer controls.

Guideline-Based Recommendations

Diagnosis

  • Assess cancer survivors for heart failure risk using clinical history and risk factor profiling.
  • Evaluate modifiable risk factors including blood pressure, BMI, LDL cholesterol, HbA1c, renal function, smoking status, physical activity, and diet quality.

Management

  • Implement comprehensive risk factor control targeting at least five modifiable factors to reduce heart failure risk.
  • Promote smoking cessation, regular physical activity, healthy diet, and control of blood pressure, glucose, and lipids.
  • Monitor and manage cardiotoxic effects of cancer therapies such as anthracyclines and thoracic radiotherapy.

Monitoring & Follow-up

  • Regularly monitor cardiovascular risk factors and cardiac function in cancer survivors.
  • Use longitudinal follow-up to assess effectiveness of risk factor control on heart failure incidence.

Risks

  • Cancer treatments can cause cardiotoxicity leading to increased heart failure risk.
  • Uncontrolled hypertension, diabetes, obesity, and smoking exacerbate heart failure risk in cancer survivors.

Patient & Prescribing Data

Cancer survivors matched with non-cancer controls from UK Biobank cohort

Each additional controlled risk factor reduces heart failure risk by 12%; controlling at least five risk factors yields a 24% lower risk compared to lowest control group.

Clinical Best Practices

  • Adopt a multidimensional lifestyle approach including environment, sleep, emotion, exercise, and diet (Healthy E(e)SEEDi pattern).
  • Use propensity score matching to identify comparable control populations in research.
  • Focus on early identification and joint management of multiple modifiable risk factors to prevent heart failure in cancer survivors.

References

Original Source(s)

Related Content